» Articles » PMID: 31023832

Low Plasma Vitamin D is Associated with Adverse Colorectal Cancer Survival After Surgical Resection, Independent of Systemic Inflammatory Response

Overview
Journal Gut
Specialty Gastroenterology
Date 2019 Apr 27
PMID 31023832
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We assessed the effect of surgical resection of colorectal cancer (CRC) on perioperative plasma vitamin D (25OHD) and C-reactive protein (CRP) level. We investigated the relationship between circulating vitamin D level and CRC survival.

Design: We sequentially sampled 92 patients undergoing CRC resection, and measured plasma 25OHD and CRP. For survival analyses, we assayed 25OHD and CRP in two temporally distinct CRC patient cohorts (n=2006, n=2100) and investigated the association between survival outcome, circulating vitamin D and systemic inflammatory response.

Results: Serial sampling revealed a postoperative fall (mean 17.3 nmol/L; p=3.6e-9) in plasma 25OHD (nadir days 1-2). CRP peaked 3-5 days postoperatively (143.1 mg/L; p=1.4e-12), yet the postoperative fall in 25OHD was independent of CRP. In cohort analyses, 25OHD was lower in the 12 months following operation (mean=48.8 nmol/L) than preoperatively (54.8 nmol/L; p=1.2e-5) recovering after 24 months (52.2 nmol/L; p=0.002). Survival analysis in American Joint Committee on Cancer stages I-III demonstrated associations between 25OHD tertile and CRC mortality (HR=0.69; 95% CI 0.46 to 0.91) and all-cause mortality (HR=0.68; 95% CI 0.50 to 0.85), and was independent of CRP. We observed interaction effects between plasma 25OHD and rs11568820 genotype (functional polymorphism) with a strong protective effect of higher 25OHD only in patients with GG genotype (HR=0.51; 95% CI 0.21 to 0.81). We developed an online tool for predicted survival (https://apps.igmm.ed.ac.uk/mortalityCalculator/) that incorporates 25OHD with clinically useful predictive performance (area under the curve 0.77).

Conclusions: CRC surgery induces a fall in circulating 25OHD. Plasma 25OHD level is a prognostic biomarker with low 25OHD associated with poorer survival, particularly in those with rs11568820 GG genotype. A randomised trial of vitamin D supplementation after CRC surgery has compelling rationale.

Citing Articles

The Immunomodulatory Role of Vitamin D in Regulating the Th17/Treg Balance and Epithelial-Mesenchymal Transition: A Hypothesis for Gallbladder Cancer.

Cartes-Velasquez R, Vera A, Torres-Quevedo R, Medrano-Diaz J, Perez A, Munoz C Nutrients. 2024; 16(23).

PMID: 39683528 PMC: 11643987. DOI: 10.3390/nu16234134.


Plasma 25-hydroxyvitamin D deficiency in the peri-operative period is associated with survival outcome in colorectal cancer patients: a meta-analysis.

Zheng B, Chen J, Gong X BMC Surg. 2024; 24(1):180.

PMID: 38867218 PMC: 11167935. DOI: 10.1186/s12893-024-02473-5.


Circulating 25-hydroxyvitamin D and survival outcomes of colorectal cancer: evidence from population-based prospective cohorts and Mendelian randomisation.

Zhang X, He Y, Li X, Shraim R, Xu W, Wang L Br J Cancer. 2024; 130(9):1585-1591.

PMID: 38480934 PMC: 11058806. DOI: 10.1038/s41416-024-02643-5.


Vitamin D Status, Genotype, and Colorectal Cancer Survival: Population-Based Patient Cohort.

Gwenzi T, Schrotz-King P, Schottker B, Hoffmeister M, Brenner H Nutrients. 2023; 15(12).

PMID: 37375621 PMC: 10305330. DOI: 10.3390/nu15122717.


Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance).

Wang Q, Ma C, Yuan C, Shi Q, Wolpin B, Zhang Y Clin Cancer Res. 2023; 29(14):2621-2630.

PMID: 37289007 PMC: 10524689. DOI: 10.1158/1078-0432.CCR-23-0447.


References
1.
Ng K, Meyerhardt J, Wu K, Feskanich D, Hollis B, Giovannucci E . Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin Oncol. 2008; 26(18):2984-91. DOI: 10.1200/JCO.2007.15.1027. View

2.
Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis J . Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ. 2014; 348:g2035. PMC: 3972415. DOI: 10.1136/bmj.g2035. View

3.
Fedirko V, Riboli E, Tjonneland A, Ferrari P, Olsen A, Bueno-de-Mesquita H . Prediagnostic 25-hydroxyvitamin D, VDR and CASR polymorphisms, and survival in patients with colorectal cancer in western European ppulations. Cancer Epidemiol Biomarkers Prev. 2012; 21(4):582-93. PMC: 3378514. DOI: 10.1158/1055-9965.EPI-11-1065. View

4.
Zgaga L, Theodoratou E, Farrington S, Din F, Ooi L, Glodzik D . Plasma vitamin D concentration influences survival outcome after a diagnosis of colorectal cancer. J Clin Oncol. 2014; 32(23):2430-9. DOI: 10.1200/JCO.2013.54.5947. View

5.
Reid D, Toole B, Knox S, Talwar D, Harten J, OReilly D . The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. Am J Clin Nutr. 2011; 93(5):1006-11. DOI: 10.3945/ajcn.110.008490. View